ARCHIVES

“Sloppy Work” May Invalidate Methylene Chloride Study; Contractor Hints NTP Pressured By Industry

This article is from The Cancer Letter archive.

Vol. 09 No. 39 | October 14, 1983

Download PDF Visit The Full Archive

Related Articles

NeoRx Suspends Accrual, Treatment In Phase III trial Using STR For Myeloma.

December 1, 2000

Review Of Organ Site Program Requested By NCAB Set For Nov. 23-25; Eight Member Committee Named

August 21, 1981

Phase II ThermoDox Trial Demonstrates Positive Response

August 29, 2014

Velcade Plus Dexamethasone Provides 20% Response In First-Line Treatment

December 29, 2006

NCAB Gives Okay To Comp Center Guidelines

December 7, 1979

In Brief: Senate Committee Confirms Varmus; Albertini Directs Vermont Cancer Center

November 19, 1993